Stay up-to-date with the latest Capital Group Core Balanced ETF (CGBL) stock price. View CGBL stock price chart and historical prices to make forecasts and predictions.
(2) It starts with a large bearish or moderate bearish candlestick, with the next day's stock price sharply breaking below the previous day's lowest point, but soon the market pushes the stock price back up, forming a large bullish or moderate bullish candlestick, where the closing price ...
A high-level overview of The Carlyle Group Inc. (CG) stock. View (CG) real-time stock price, chart, news, analysis, analyst reviews and more.
XNAS: CG | 04:00 PM GMT+8 40.76 price (usd) 1.60(4.09%) daily change 52 week low 33.02 52 week high 57.50 See Full Interactive Chart Last Quarterly Earnings Rose Open 39.94 Previous Close 39.16 Bid 38.92 x 100 Ask 41.20 x 100 Market Cap 14.13B P/E Ratio (ttm) 14.65 Beta 1.6673...
Spreads Protection Strategies Straddles & Strangles Horizontal Spreads Butterfly Spreads Condor Strategies company News & Headlines Key Statistics SEC Filings Competitors Stock Comparison Insider Trades analysts Earnings Estimates Analyst Ratings financials Financial Summary Income Statement Balance Sheet Cash Flow...
Today 9:50 am CGDV - Capital Group Dividend Value ETF New 1-year High. First new high in 23 trading days. Apr 4 9:45 am CGDV - Capital Group Dividend Value ETF New 1-year High. Last new high was on Apr 1. Apr 1 9:50 am ...
CGFYX Edit my quotes Columbia Large Cap Growth Fund Class I3(CGFYX) $71.23 -0.58(-0.81%) May 6, 2025 Showing chart data for 1 month May 6, 2025 Created with Highcharts 11.4.8Apr 08Apr 12Apr 16Apr 22Apr 26Apr 30May 06Highcharts.com ...
quotes Price Overview Performance Report charts Interactive Chart Snapshot Chart technicals Barchart Opinion Trading Strategies Top Trade Alerts Technical Analysis Trader's Cheat Sheet Seasonal Returns Price History Historical Data options Options Prices Volatility & Greeks Options Flow Options Time & Sales...
Stock Price22.37 Revenue$0000 View About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company developing oncolytic immunotherapies for bladder cancer. The company's product, cretostimogene grenadenorepvec, is an investigational engineered oncolytic immunotherapy designed to treat patient...
Trading ex-dividend today. $0.0455/shr Jul 19 9:50 am CGMU - Capital Grp Municipal Income ETF New 1-year High. Last new high was on Jul 16. Jul 16 9:50 am CGMU - Capital Grp Municipal Income ETF New 1-year High. Last new high was on Jul 12. ...